Glaxo, Roche Drugs Help Treat Breast Cancer in Brain
Glaxo, Roche Drugs Help Treat Breast Cancer in Brain
Filed under: drug treatment news 2012
GlaxoSmithKline (GSK) Plc's breast cancer pill Tykerb, used with Roche Holding AG (ROG)'s drug Xeloda, helped treat the disease's spread to the brain, according to a study. The treatments shrank the size of brain tumors by at least 50 percent in two …
Read more on Bloomberg
VIVUS Reports Third Quarter and First Nine Months 2012 Financial Results
Filed under: drug treatment news 2012
Our drug, STENDRA (avanafil), was approved by the FDA on April 27, 2012 for the treatment of erectile dysfunction, or ED. STENDRA is a phosphodiesterase 5, or PDE5, inhibitor indicated for the treatment of ED. In March 2012, we submitted and the …
Read more on NASDAQ
Drug showed promise in clearing drug-resistant tuberculosis
Filed under: drug treatment news 2012
However, most of the patients – 82 percent – experienced side effects while on the treatment, which tempered the findings, the team reported. "That is the bad news," Fauci said. "The somewhat encouraging news is that despite the toxicity, when the drug …
Read more on Reuters
Novartis says may have 14 new blockbuster drugs by 2017
Filed under: drug treatment news 2012
ZURICH | Thu Nov 8, 2012 8:31am EST. ZURICH (Reuters) – Novartis could … Among its most promising products are serelaxin and LCZ686 to treat patients with heart failure as well as drugs for psoriasis and multiple sclerosis. It plans to file serelaxin …
Read more on Reuters